A 58-year-old man with a 10-year history of type 2 diabetes mellitus presents to the emergency department with acute onset severe hypotension (BP 70/45 mmHg) and altered mental status following a bout of acute gastroenteritis with profuse diarrhea and vomiting. Physical examination reveals cold, clammy extremities, weak peripheral pulses, and poor capillary refill. Urine output has dropped to 0.3 mL/kg/hr. After rapid fluid resuscitation with 2 L of normal saline, BP remains 78/48 mmHg. Which of the following adrenergic agonists would be the most appropriate choice for this patient at this stage?

Explanation

## Clinical Context: Septic Shock with Refractory Hypotension This patient has signs of distributive shock (septic shock secondary to acute gastroenteritis) with evidence of: - Severe hypotension unresponsive to fluid resuscitation - Peripheral hypoperfusion (cold extremities, weak pulses, poor capillary refill) - Oliguria (0.3 mL/kg/hr) - Altered mental status (end-organ hypoperfusion) ## Why Noradrenaline is the Correct Choice **Key Point:** Noradrenaline (norepinephrine) is the first-line vasopressor in septic shock refractory to fluid resuscitation, as endorsed by the Surviving Sepsis Campaign guidelines. **High-Yield:** Noradrenaline combines: - **α₁-adrenergic effects** → potent vasoconstriction → restores systemic vascular resistance and mean arterial pressure - **β₁-adrenergic effects** → maintains cardiac contractility and heart rate → prevents reflex bradycardia seen with pure α-agonists - **Renal perfusion preservation** → maintains urine output better than pure vasoconstrictors **Clinical Pearl:** In septic shock, the combination of vasoconstriction + inotropic support is essential. Noradrenaline achieves both in a single agent, making it superior to single-action drugs in this setting. ## Comparison of Adrenergic Agonists in Shock | Agent | α₁ | β₁ | β₂ | Clinical Use | Limitation | |-------|-----|-----|-----|-------|----------| | **Noradrenaline** | +++++ | ++ | — | **Septic shock (1st-line)** | Potential for vasoconstriction-induced tissue ischemia if excessive | | Phenylephrine | +++++ | — | — | Pure vasoconstriction only | Causes reflex bradycardia; no inotropy; worsens renal perfusion | | Dopamine (2–5 μg/kg/min) | ++ | +++ | — | Cardiogenic shock; bradycardia | Tachycardia risk; less predictable in sepsis | | Isoproterenol | — | +++++ | +++++ | Bradycardia + low output | Causes systemic vasodilation; worsens hypotension in sepsis; increases myocardial O₂ demand | **Mnemonic: NORA for Noradrenaline in Sepsis** — **N**oradrenaline, **O**verall best, **R**estores resistance, **A**nd maintains inotropy. ## Why Other Options Fail in This Scenario 1. **Phenylephrine** — Pure α₁ agonist; restores BP but causes reflex bradycardia and worsens renal/splanchnic perfusion due to lack of β₁ support. 2. **Dopamine (low dose)** — At 2–5 μg/kg/min, dopamine is primarily dopaminergic (renal vasodilation) with weak β₁ effects; insufficient for severe septic shock requiring both vasoconstriction and inotropy. 3. **Isoproterenol** — Pure β-agonist (β₁ + β₂); causes systemic vasodilation and worsens hypotension; increases heart rate and myocardial oxygen demand without addressing the underlying vasodilatory pathophysiology of sepsis. ## Dosing and Administration **Noradrenaline infusion:** 0.01–0.05 μg/kg/min IV, titrated to target mean arterial pressure ≥65 mmHg. Requires central line for safe administration. **Key Point:** Fluid resuscitation should continue in parallel; vasopressors are adjunctive, not a replacement for fluid therapy.